01 October 2006
Role of sphingosine kinase activity in protection of heart against ischemia reperfusion injury
Donald A. Vessey, Michael Kelley, Luyi Li, Yong Huang, Hui-Zhong Zhou, Bo Qing Zhu, Joel S. KarlinerMed Sci Monit 2006; 12(10): BR318-324 :: ID: 459167
Abstract
Background: Sphingosine kinase (SKase) has been implicated in the protection of hearts from ischemia/reperfusion injury. This hypothesis was further examined.
Matreial/Methods: Changes in SKase activity and cardiac function (left ventricular developed pressure, LVDP, and infarct size) in response to ischemia and reperfusion were studied in adult rat hearts by the ex vivo Langendorff method. Following initial equilibration or preconditioning, there was 45 min no-fl ow ischemia and then 45 min of reperfusion.
Results: SKase activity declined 61% during ischemia and did not recover upon reperfusion. LVDP also
did not recover upon reperfusion and the infarct size was 47%. A short 30 min period of ischemia
was associated with variable recovery of SKase activity that directly correlated with LVDP recovery.
Preconditioning of hearts reduced the decrease in SKase activity during ischemia by half, and
upon reperfusion activity returned to normal. The LVDP recovered 79% and infarct size was small.
Preconditioned hearts had higher S-1-P levels after ischemia/reperfusion relative to non-preconditioned
hearts. The decline in SKase activity during ischemia of preconditioned hearts could not be mimicked in vitro by treatment with protein phosphatases. Attempts to alter activity of SKase from control, preconditioned, ischemic, or reperfused hearts by phosphorylation with ERK1/2 were unsuccessful. Treatment of non-preconditioned hearts at reperfusion with 100 nM S-1-P improved recovery of LVDP. The SKase inhibitor dimethylsphingosine blocked hemodynamic recovery in preconditioned hearts.
Conclusions: The data support a role for SKase activity in recovery of hemodynamic function after ischemic injury and also in the cardioprotective effect of preconditioning.
Keywords: Ischemic Preconditioning, Myocardial, Myocardial Infarction - physiopathology, Myocardial Reperfusion Injury - prevention & control, Myocardium - enzymology, Phosphotransferases (Alcohol Group Acceptor) - metabolism, Subcellular Fractions - enzymology, Ventricular Pressure
Editorial
01 October 2024 : Editorial
Editorial: Potentials and Pitfalls in Targeting Glucagon-Like Peptide-1 (GLP-1) in the Management of Increasing Levels of ObesityDOI: 10.12659/MSM.946675
Med Sci Monit 2024; 30:e946675
In Press
Clinical Research
Impact of Manual Sustained Inflation vs Stepwise PEEP on Pulmonary and Cerebral Outcomes in Carotid Endarte...Med Sci Monit In Press; DOI: 10.12659/MSM.944936
Clinical Research
Predicting Vaginal Delivery Success: Role of Intrapartum Transperineal Ultrasound Angle of Descent at a Sin...Med Sci Monit In Press; DOI: 10.12659/MSM.945458
Review article
Comprehensive Analysis of UBE-Related Complications: Prevention and Management Strategies from 4685 PatientsMed Sci Monit In Press; DOI: 10.12659/MSM.944018
Clinical Research
Predicting Neonatal Hypoglycemia Using AI Neural Networks in Infants from Mothers with Gestational Diabetes...Med Sci Monit In Press; DOI: 10.12659/MSM.944513
Most Viewed Current Articles
17 Jan 2024 : Review article 6,056,766
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research 1,848,323
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research 693,672
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
07 Jan 2022 : Meta-Analysis 257,970
Efficacy and Safety of Light Therapy as a Home Treatment for Motor and Non-Motor Symptoms of Parkinson Dise...DOI :10.12659/MSM.935074
Med Sci Monit 2022; 28:e935074